GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » ROE % Adjusted to Book Value

Biosyntech (Biosyntech) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2009)


View and export this data going back to 2000. Start your Free Trial

What is Biosyntech ROE % Adjusted to Book Value?

Biosyntech's ROE % for the quarter that ended in Dec. 2009 was 0.00%. Biosyntech's PB Ratio for the quarter that ended in Dec. 2009 was N/A. Biosyntech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2009 was N/A.


Biosyntech ROE % Adjusted to Book Value Historical Data

The historical data trend for Biosyntech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech ROE % Adjusted to Book Value Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -38.67 -19.00 -11.18 -

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biosyntech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Biosyntech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biosyntech's ROE % Adjusted to Book Value falls into.



Biosyntech ROE % Adjusted to Book Value Calculation

Biosyntech's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2009 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Biosyntech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2009 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosyntech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biosyntech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyntech (Biosyntech) Business Description

Industry
Traded in Other Exchanges
N/A
Address
475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines